BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

811 related articles for article (PubMed ID: 30563755)

  • 21. Interplay between Cytokine Circuitry and Transcriptional Regulation Shaping Helper T Cell Pathogenicity and Plasticity in Inflammatory Bowel Disease.
    Fu SH; Chien MW; Hsu CY; Liu YW; Sytwu HK
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32403220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biologic therapies against inflammatory bowel disease: a dysregulated immune system and the cross talk with gastrointestinal mucosa hold the key.
    Dharmani P; Chadee K
    Curr Mol Pharmacol; 2008 Nov; 1(3):195-212. PubMed ID: 20021434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Innate Lymphoid Cells in Intestinal Homeostasis and Inflammatory Bowel Disease.
    Saez A; Gomez-Bris R; Herrero-Fernandez B; Mingorance C; Rius C; Gonzalez-Granado JM
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deletion of IL-6 Exacerbates Colitis and Induces Systemic Inflammation in IL-10-Deficient Mice.
    Ye M; Joosse ME; Liu L; Sun Y; Dong Y; Cai C; Song Z; Zhang J; Brant SR; Lazarev M; Li X
    J Crohns Colitis; 2020 Jul; 14(6):831-840. PubMed ID: 31679013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The innate immune system and inflammatory bowel disease.
    Davies JM; Abreu MT
    Scand J Gastroenterol; 2015 Jan; 50(1):24-33. PubMed ID: 25523553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease.
    Geremia A; Arancibia-Cárcamo CV; Fleming MP; Rust N; Singh B; Mortensen NJ; Travis SP; Powrie F
    J Exp Med; 2011 Jun; 208(6):1127-33. PubMed ID: 21576383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alterations in cytokine gene expression profile in colon mucosa of Inflammatory Bowel Disease patients on different therapeutic regimens.
    Velikova T; Kyurkchiev D; Spassova Z; Karakolev I; Ivanova-Todorova E; Altankova I; Stanilova S
    Cytokine; 2017 Apr; 92():12-19. PubMed ID: 28088612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibiting Interleukin 36 Receptor Signaling Reduces Fibrosis in Mice With Chronic Intestinal Inflammation.
    Scheibe K; Kersten C; Schmied A; Vieth M; Primbs T; Carlé B; Knieling F; Claussen J; Klimowicz AC; Zheng J; Baum P; Meyer S; Schürmann S; Friedrich O; Waldner MJ; Rath T; Wirtz S; Kollias G; Ekici AB; Atreya R; Raymond EL; Mbow ML; Neurath MF; Neufert C
    Gastroenterology; 2019 Mar; 156(4):1082-1097.e11. PubMed ID: 30452921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opposing consequences of IL-23 signaling mediated by innate and adaptive cells in chemically induced colitis in mice.
    Cox JH; Kljavin NM; Ota N; Leonard J; Roose-Girma M; Diehl L; Ouyang W; Ghilardi N
    Mucosal Immunol; 2012 Jan; 5(1):99-109. PubMed ID: 22089030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD4CD8αα lymphocytes, a novel human regulatory T cell subset induced by colonic bacteria and deficient in patients with inflammatory bowel disease.
    Sarrabayrouse G; Bossard C; Chauvin JM; Jarry A; Meurette G; Quévrain E; Bridonneau C; Preisser L; Asehnoune K; Labarrière N; Altare F; Sokol H; Jotereau F
    PLoS Biol; 2014 Apr; 12(4):e1001833. PubMed ID: 24714093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intestinal IFN-γ-producing type 1 regulatory T cells coexpress CCR5 and programmed cell death protein 1 and downregulate IL-10 in the inflamed guts of patients with inflammatory bowel disease.
    Alfen JS; Larghi P; Facciotti F; Gagliani N; Bosotti R; Paroni M; Maglie S; Gruarin P; Vasco CM; Ranzani V; Frusteri C; Iseppon A; Moro M; Crosti MC; Gatti S; Pagani M; Caprioli F; Abrignani S; Flavell RA; Geginat J
    J Allergy Clin Immunol; 2018 Nov; 142(5):1537-1547.e8. PubMed ID: 29369775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased expression of interleukin 17 in inflammatory bowel disease.
    Fujino S; Andoh A; Bamba S; Ogawa A; Hata K; Araki Y; Bamba T; Fujiyama Y
    Gut; 2003 Jan; 52(1):65-70. PubMed ID: 12477762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of T Helper 1 Cytokine Gene Single Nucleotide Polymorphisms with Ulcerative Colitis and Crohn's Disease.
    Ebrahimi Daryani N; Sadr M; Soltani S; Saghazadeh A; Moossavi S; Shahkarami S; Farhadi E; Rezaei N
    Dig Dis; 2019; 37(1):21-32. PubMed ID: 30134230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histamine Receptor 2 is Required to Suppress Innate Immune Responses to Bacterial Ligands in Patients with Inflammatory Bowel Disease.
    Smolinska S; Groeger D; Perez NR; Schiavi E; Ferstl R; Frei R; Konieczna P; Akdis CA; Jutel M; OʼMahony L
    Inflamm Bowel Dis; 2016 Jul; 22(7):1575-86. PubMed ID: 27271490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The IL-23/IL-17 pathway in inflammatory bowel disease.
    Geremia A; Jewell DP
    Expert Rev Gastroenterol Hepatol; 2012 Apr; 6(2):223-37. PubMed ID: 22375527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective immunomodulation in patients with inflammatory bowel disease--future therapy or reality?
    van Hogezand RA; Verspaget HW
    Neth J Med; 1996 Feb; 48(2):64-7. PubMed ID: 8819802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of interleukin 1 beta and interleukin 1 beta converting enzyme by intestinal macrophages in health and inflammatory bowel disease.
    McAlindon ME; Hawkey CJ; Mahida YR
    Gut; 1998 Feb; 42(2):214-9. PubMed ID: 9536946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colonic expression of the peptide transporter PEPT1 is downregulated during intestinal inflammation and is not required for NOD2-dependent immune activation.
    Wuensch T; Ullrich S; Schulz S; Chamaillard M; Schaltenberg N; Rath E; Goebel U; Sartor RB; Prager M; Büning C; Bugert P; Witt H; Haller D; Daniel H
    Inflamm Bowel Dis; 2014 Apr; 20(4):671-84. PubMed ID: 24583477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimental colitis in IL-10-deficient mice ameliorates in the absence of PTPN22.
    Jofra T; Galvani G; Cosorich I; De Giorgi L; Annoni A; Vecchione A; Sorini C; Falcone M; Fousteri G
    Clin Exp Immunol; 2019 Sep; 197(3):263-275. PubMed ID: 31194881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of heat shock protein a4/apg-2 in refractory inflammatory bowel disease.
    Adachi T; Sakurai T; Kashida H; Mine H; Hagiwara S; Matsui S; Yoshida K; Nishida N; Watanabe T; Itoh K; Fujita J; Kudo M
    Inflamm Bowel Dis; 2015 Jan; 21(1):31-9. PubMed ID: 25437815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.